phosphoinositid
pi
lipid
play
crucial
role
membran
traffick
pi
tightli
regul
spatial
tempor
mani
pi
kinas
phosphatas
distribut
throughout
differ
intracellular
compart
potenti
role
pi
pi
kinas
life
cycl
virus
studi
extens
exampl
appear
play
predomin
role
regul
ebola
viru
entri
sever
virus
also
activ
infect
vsv
influenza
viru
addit
sever
group
identifi
cofactor
hepat
c
viru
hcv
replic
hcv
nonstructur
protein
demonstr
interact
stimul
kinas
activ
recent
shown
key
cellular
protein
exploit
sever
plusstrand
rna
virus
replic
lipid
microenviron
essenti
enterovir
rna
replic
april
novel
coronaviru
sar
coronaviru
sarscov
identifi
etiolog
agent
sever
acut
respiratori
syndrom
sar
sarscov
envelop
positivestrand
rna
viru
function
receptor
sarscov
respons
mediat
sarscov
entri
host
cell
understand
molecular
basi
sarscov
target
cell
critic
unravel
mechan
pathogenesi
sarscov
enter
cell
direct
fusion
plasma
membran
studi
primarili
use
pseudotyp
viru
system
shown
sarscov
entri
phdepend
suggest
endosom
proteas
cathepsin
l
may
involv
entri
apart
observ
key
cellular
factor
shown
specif
involv
sarscov
life
cycl
studi
reveal
role
sarscov
smediat
entri
first
studi
demonstr
requir
cell
entri
mediat
sarscov
function
depend
upon
kinas
activ
interestingli
found
product
catalysi
creat
lipid
microenviron
requir
sarscov
smediat
entri
result
provid
import
insight
life
cycl
sarscov
suggest
may
potenti
therapeut
target
near
futur
cell
african
green
monkey
kidney
cell
line
cell
human
embryon
kidney
cell
line
american
type
cultur
collect
propag
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
unitsml
penicillin
unitsml
streptomycin
polyclon
antibodi
obtain
millipor
billerica
monoclon
antibodi
antiflag
antibodi
antihuman
fc
antibodi
purchas
sigma
polyclon
antibodi
purchas
r
system
minneapoli
mn
antigfp
antibodi
obtain
santa
cruz
biotechnolog
santa
cruz
ca
mous
monoclon
antibodi
obtain
echelon
bioscienc
salt
lake
citi
ut
wortmannin
dmso
hoechst
tpcktrypsin
proteinas
k
purchas
sigma
pseudovirus
produc
describ
previous
briefli
cell
cotransfect
pqcxix
vector
spikeencod
plasmid
provid
dr
michael
farzan
control
plasmid
vsvg
gagpol
express
plasmid
enhanc
gfp
gene
insert
pqcxix
vector
h
posttransfect
viru
supernat
harvest
filter
filter
requir
virion
concentr
ultracentrifug
g
rotor
beckman
instrument
h
pellet
resuspend
dmem
store
viral
titer
determin
describ
previous
cell
treat
indic
concentr
dmso
min
next
cell
incub
pseudoviru
h
presenc
drug
fresh
medium
ad
cell
incub
h
cell
fix
paraformaldehyd
pb
room
temperatur
rt
min
cell
nuclei
stain
hoechst
dilut
pb
min
rt
imag
captur
use
nikon
eclips
invert
fluoresc
microscop
analyz
imagepro
plu
softwar
media
cybernet
sirna
use
studi
obtain
ribobio
guanzhou
china
transfect
cell
seed
cellswel
plate
follow
day
cell
transfect
lipofectamin
rnaimax
reagent
invitrogen
nm
sirna
optimem
invitrogen
h
cell
trypsin
seed
plate
h
postsirna
transfect
experiment
viru
infect
perform
protein
sampl
separ
sdspolyacrylamid
gel
transfer
nitrocellulos
membran
probe
primari
antibodi
protein
visual
hrpconjug
secondari
antibodi
chemiluminesc
substrat
santa
cruz
biotechnolog
expos
film
cell
seed
plate
dmso
dilut
dmem
ad
cell
follow
day
incub
cell
cultur
medium
remov
new
dmem
ad
cell
experiment
group
includ
triplic
well
celltit
aqueou
one
solut
cell
prolifer
assay
buffer
promega
ad
well
cultur
incub
addit
h
absorb
record
nm
sirna
treatment
cell
viabil
determin
h
sirna
transfect
total
rna
harvest
cell
use
trizol
reagent
invitrogen
analysi
host
gene
express
cellular
rna
reversetranscrib
amplifi
pcr
use
superscripttm
iii
platinum
onestep
quantit
rtpcr
system
platinum
taq
invitrogen
taqman
gene
express
assay
appli
biosystem
cellular
rna
normal
gapdh
level
data
analyz
rel
sicontroltr
cell
assay
perform
abi
system
analyz
sd
appli
biosystem
h
posttransfect
sirna
cell
trypsin
collect
eppendorf
tube
cultur
incub
antibodi
h
three
wash
pb
cell
incub
alexa
fluor
secondari
antibodi
fixat
paraformaldehyd
sampl
analyz
beckman
coulter
epic
elit
esp
instrument
cell
grown
glass
coverslip
rins
pb
fix
paraformaldehyd
pb
min
rt
follow
quench
mm
pb
min
rt
cell
block
permeabil
saponin
fb
pb
h
rt
cell
incub
primari
antibodi
block
buffer
overnight
follow
three
wash
pb
alexa
secondari
antibodi
invitrogen
use
dilut
block
buffer
three
wash
pb
cell
nuclei
stain
hoechst
sigma
pb
min
rt
immunostain
immunostain
cell
incub
antiflag
primari
antibodi
block
buffer
h
rt
follow
three
wash
pb
alexa
secondari
antibodi
invitrogen
use
dilut
block
buffer
imag
captur
use
confoc
laserscan
microscopi
leica
tc
analyz
leica
confoc
softwar
sarscov
rbr
express
chimer
protein
human
iggfc
protein
express
cell
recombin
protein
purifi
protein
gagaros
bead
ge
healthcar
viru
fc
protein
bound
cell
indic
concentr
h
unbound
viru
protein
remov
wash
cell
either
lyse
measur
bound
viru
protein
incub
h
allow
intern
treat
mgml
proteinas
k
prior
lysi
remov
unintern
viru
neutral
experi
sar
pseudoviru
preincub
antisar
spikeneutr
antibodi
irrelev
isotypematch
control
antibodi
h
rt
sar
pseudoviru
ad
cell
viru
bind
intern
assay
cell
transfect
confluenc
express
vector
empti
vector
transfect
perform
xtremegen
hp
reagent
follow
manufactur
instruct
roch
appli
scienc
viru
infect
experi
perform
h
posttransfect
cell
preincub
min
dmem
presenc
absenc
cell
spininfect
pseudoviru
g
min
medium
chang
cell
incub
tpcktrypsin
pb
alon
min
trypsin
remov
dmem
without
ad
h
medium
replac
fresh
dmem
contain
fb
cell
analyz
gfp
express
h
cell
seed
duplic
sixwel
plate
one
lipid
extract
one
cell
count
hemocytomet
equival
number
cell
million
collect
extract
accord
detail
protocol
mass
strip
kit
echelon
bioscienc
lipid
spot
onto
nitrocellulos
membran
prespot
pi
standard
visual
detector
chemiluminesc
reagent
santa
cruz
biotechnolog
data
shown
mean
se
statist
analys
perform
use
student
test
assess
effici
viru
entri
produc
gfpcontain
pseudoviru
sarscov
envelop
glycoprotein
spike
vsvg
protein
vsvp
infect
cell
fluoresc
green
microscopi
first
screen
sever
chemic
known
kinas
inhibitor
determin
effect
sarscov
smediat
entri
found
pi
kinas
inhibitor
significantli
inhibit
entri
sar
pseudovirion
cell
wherea
entri
vsvg
pseudoviru
affect
fig
cell
viabil
assay
demonstr
signific
effect
growth
experi
fig
inhibit
entri
dosedepend
manner
fig
treatment
strongli
inhibit
sarscov
smediat
entri
addit
observ
similar
result
use
western
blot
analysi
quantifi
gfp
express
detect
viru
entri
fig
anoth
pi
kinas
inhibitor
wortmannin
also
inhibit
sarscov
smediat
entri
cell
effect
vsvg
pseudoviru
entri
fig
found
entri
sar
pseudovirion
cell
inhibit
wortmannin
nm
fig
consist
result
report
type
iii
wortmannin
treatment
nm
concentr
effici
inhibit
pi
signific
effect
sarscov
smediat
entri
signific
cytotox
wortmannin
treatment
concentr
fig
final
total
gfp
express
sarscov
smediat
entri
also
decreas
cell
pretreat
wortmannin
fig
wortmannin
pi
kinas
inhibitor
target
sever
pi
kinas
type
iii
knowledg
function
mammalian
cell
well
defin
studi
sought
identifi
type
pi
kinas
affect
wortmannin
given
major
import
subunit
among
subunit
subunit
assess
follow
experi
design
seri
correspond
sirna
test
effect
knock
individu
gene
viru
entri
without
signific
effect
cell
viabil
tabl
quantit
rtpcr
result
demonstr
sirna
use
effici
inhibit
target
gene
express
wherea
control
sirna
littl
effect
fig
fluoresc
microscopi
show
signific
inhibit
sarscov
smediat
entri
sirna
transfect
compar
control
sirnatr
cell
wherea
knockdown
signific
effect
sarscov
smediat
entri
convers
sarscov
smediat
entri
increas
transfect
sirna
cell
fig
contrast
pi
kinas
sirna
effect
vsvg
entri
cell
fig
statist
analysi
demonstr
signific
observ
fig
silenc
three
individu
sirna
duplex
strongli
inhibit
sarscov
smediat
entri
confirm
western
blot
analysi
fig
moreov
sirna
duplex
potent
transcript
silenc
inhibit
sarscov
smediat
entri
result
conclud
wortmannin
inhibit
sar
pseudoviru
entri
target
involv
sarscov
smediat
entri
cell
interestingli
oppos
role
sarscov
smediat
entri
cell
suggest
differ
role
process
may
link
specif
kinas
activ
previou
studi
establish
respons
product
present
cell
wherea
convert
phosphatidylinositol
therebi
decreas
concentr
previou
result
suggest
level
may
main
reason
demonstr
differ
function
sarscov
smediat
entri
investig
whether
kinas
activ
could
account
differ
effect
pi
kinas
sarscov
smediat
entri
test
whether
lipid
directli
regul
viral
entri
independ
cell
transient
transfect
gene
pi
phosphatas
specif
convert
lipid
back
pi
phosphatas
shown
oppos
vivo
demonstr
viru
entri
assay
fig
b
sarscov
smediat
entri
reduc
cell
transient
overexpress
recombin
compar
control
cell
wherea
vsvg
pseudoviru
entri
affect
recombin
express
transient
transfect
cell
recombin
inde
present
shown
detect
flag
express
n
terminu
fig
furthermor
western
blot
analysi
show
gfp
express
sarscov
smediat
entri
decreas
recombin
cell
compar
vectortransfect
cell
fig
result
indic
indispens
sarscov
smediat
entri
suggest
mediat
sarscov
entri
regul
level
cellular
confirm
regul
sarscov
smediat
entri
control
product
monitor
level
cellular
inhibit
ectop
express
immunostain
monoclon
antibodi
reveal
enrich
within
cytoplasm
normal
cell
fig
left
panel
howev
immunofluoresc
lost
treatment
fig
right
panel
addit
reduct
sirna
knockdown
greatli
affect
level
cell
fig
parallel
lipid
extract
prepar
sirnatransfect
cell
probe
content
use
mass
strip
contain
known
load
standard
shown
inhibit
greater
effect
lower
level
cell
compar
inhibit
wherea
inhibit
increas
level
fig
c
effect
level
cell
accord
effect
sarscov
smediat
entri
result
suggest
respons
product
next
monitor
effect
recombin
express
level
cell
transient
transfect
express
plasmid
transfect
cell
fig
red
visual
indirect
immunofluoresc
use
antiflag
antibodi
green
detect
antibodi
confoc
imag
show
level
cell
lower
nontransfect
cell
fig
detect
lipid
extract
cell
transfect
control
plasmid
reveal
ectop
express
reduc
level
fig
f
g
result
demonstr
phosphatas
key
factor
regul
level
cell
previou
studi
shown
viru
entri
multistep
process
primari
step
often
initi
low
affin
bind
attach
site
promot
concentr
virion
cell
surfac
subsequ
bind
high
affin
receptor
trigger
cell
entri
viru
bind
entri
envelop
virus
cell
known
occur
via
two
primari
pathway
membran
fusion
endocytosi
determin
whether
facilit
sarscov
entri
via
sever
stage
via
one
specif
stage
protein
cell
surfac
character
fac
sirna
transfect
control
sirna
pi
kinas
sirna
h
fluoresc
cell
surfac
decreas
compar
control
group
irrespect
sirna
transfect
fig
indic
level
cell
surfac
remain
constant
addit
total
protein
level
cell
affect
inhibit
pi
kinas
although
synthesi
protein
sever
inhibit
transfect
sirna
fig
addit
compar
bind
increas
quantiti
recombin
sarscov
rbr
sirnatr
cell
consist
result
signific
differ
rbr
bind
control
sirna
cell
treat
pi
kinas
sirna
fig
confirm
result
bind
sarscov
cell
quantifi
western
blot
analysi
equival
pseudoviru
bind
observ
dmso
wortmannintr
cell
fig
furthermor
detect
equival
quantiti
intern
sarscov
pseudovirion
cell
wortmannin
treatment
fig
associ
sarscov
cell
specif
neutral
antibodi
treatment
sar
coronaviru
spike
protein
almost
complet
inhibit
sarscov
bind
intern
fig
therefor
result
suggest
play
role
viru
bind
intern
viru
bind
intern
sarscov
must
fuse
membran
late
endosom
previou
studi
shown
cathepsin
l
suffici
mediat
fusion
process
addit
exogen
trypsin
cell
surfacebound
virion
bypass
cathepsin
ldepend
entri
sarscov
trypsin
promot
fusion
near
plasma
membran
local
viru
entri
investig
effect
trypsin
treatment
sar
pseudovirion
entri
cell
cell
preincub
without
infect
sarscov
vsvg
pseudovirion
expect
treatment
restrict
sarscov
smediat
entri
entri
vsvg
contrast
sarscov
bound
cell
incub
briefli
tpcktrypsin
entri
cell
restor
fig
percentag
gfpposit
cell
total
gfp
express
confirm
observ
fig
b
c
data
suggest
inhibit
restrict
trypsininduc
fusion
near
plasma
membran
function
viral
spike
protein
cleav
cathepsin
l
acid
cellular
compart
taken
togeth
data
indic
requir
viru
bind
intern
requir
viru
fusion
sarscov
entri
target
cell
uniqu
complex
process
current
sever
cellular
factor
demonstr
involv
sarscov
entri
includ
enzym
cathepsin
l
ifitm
knowledg
enzym
activ
sarscov
entri
modul
viral
entri
induc
receptor
shed
wherea
cathepsin
l
ifitmmedi
restrict
local
late
stage
endocyt
pathway
cathepsin
l
ifitm
intracellular
factor
play
oppos
role
sarscov
entri
cathepsin
l
activ
membran
fusion
function
sarscov
spike
protein
wherea
ifitm
inhibit
process
two
factor
independ
viral
receptor
express
apart
knowledg
littl
known
cellular
factor
involv
sarscov
entri
studi
first
implic
microenviron
sarscov
entri
recent
independ
function
lipid
abund
monophosphoryl
inositol
phospholipid
mammalian
cell
describ
show
lipid
alter
local
membran
curvatur
regul
select
autophagi
endoplasm
reticulum
exit
site
biogenesi
addit
lipid
specif
bind
host
protein
moreov
relationship
phosphatidylinositol
lipid
microenviron
viru
gradual
reveal
exampl
enterovirus
flavivirus
exploit
host
phosphatidylinositol
enzym
replic
respect
viral
rna
lipidenrich
membran
recent
reiss
et
al
found
elev
level
product
detect
hcvinfect
cultur
hepatocyt
liver
tissu
chronic
hepat
c
patient
exhibit
enzymat
activ
via
critic
hcv
replic
hcv
found
interact
stimul
kinas
activ
studi
examin
contradictori
role
investig
mechan
sarscov
smediat
entri
determin
indispens
element
entri
interestingli
hypothesi
demonstr
mimick
deplet
microenviron
transient
introduc
cell
howev
still
clear
whether
rna
virus
addit
sarscov
share
similar
intracellular
molecular
event
import
viral
entri
import
event
endocytosi
sarscov
cathepsin
l
proteolysi
activ
fusion
potenti
spike
protein
late
endosom
previou
studi
shown
trypsin
treatment
mediat
viru
cell
fusion
directli
near
plasma
membran
therebi
bypass
depend
cathepsin
l
entri
experi
trypsin
could
also
bypass
inhibit
suggest
assist
sarscov
entri
virion
encount
cathepsin
l
previou
studi
shown
sarscov
entri
cell
util
novel
endocyt
pathway
entri
depend
clathrin
caveolinmedi
endocytosi
therefor
specif
cellular
factor
may
provid
import
clue
elucid
novel
entri
pathway
may
key
factor
involv
sarscov
entri
although
current
limit
evid
avail
identifi
viru
entri
stage
cellular
organel
present
particip
sarscov
entri
consider
crucial
role
cathepsin
l
ifitm
sarscov
entri
work
requir
determin
intracellular
factor
mediat
sarscov
entri
step
whether
interact
interestingli
studi
subunit
may
function
inhibitor
sarscov
smediat
entri
earli
stage
whether
subunit
function
way
remain
determin
two
form
regulatori
subunit
subunit
account
major
activ
believ
knockdown
would
inhibit
function
howev
unabl
determin
whether
subunit
also
involv
sarscov
entri
therefor
research
need
studi
propos
follow
model
sar
coronaviru
spikemedi
entri
fig
facilit
sarscov
smediat
entri
without
affect
receptor
wherea
play
oppos
role
regul
microenviron
promot
entri
cathepsin
lmediat
viru
fusion
potenti
replic
futur
work
necessari
determin
factor
includ
host
cell
protein
involv
process
determin
microenviron
initi
next
step
replic
base
discoveri
cellsarscov
interact
especi
sarscov
entri
process
sever
type
inhibitor
implic
sar
treatment
enzym
antagonist
block
shed
candid
antivir
compound
small
molecul
oxocarbaz
inhibitor
human
cathepsin
l
also
shown
block
sar
pseudotyp
viru
infect
cell
studi
identifi
key
factor
involv
sarscov
smediat
entri
may
provid
potenti
target
sarscov
treatment
futur
furthermor
small
molecul
target
may
provid
basi
design
new
class
therapeut
sarscov
infect
